Delivery Order SPE2DB22D9207-SPE2DB23FH5FL
Award Date
9/28/23
Potential Completion Date
10/20/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-two thousand eight hundred sixty-eight dollars and sixty cents ($22,868.60) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the contract, DMS Pharmaceutical Group will provide four hundred fifty-six thousand two hundred thirty-three (456,233) units of 3.5 mg VELCADE vials to the Defense Logistics Agency in support of Department of Defense requirements. Performance will occur at the prime...
The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a delivery order valued at four thousand five hundred seventy-three dollars and seventy-two cents ($4,573.72) to DMS Pharmaceutical Group Inc. The firm fixed price order is for VELCADE 3.5 MG VIALS to be delivered to a location in Park Ridge, Illinois between September 11, 2023 and October 2, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency manages the...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at thirty-four thousand three hundred two dollars and ninety cents ($34,302.90) to DMS Pharmaceutical Group Incorporated. DMS will provide four hundred fifty-six thousand two hundred thirty-four thousand eighty-seven (4562345087) vials of the cancer drug Velcade (bortezomib) for injection to a military treatment facility located in Park Ridge,...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a delivery order valued at approximately $6,860 to DMS Pharmaceutical Group Inc. for VELCADE 3.5 MG VIALS. The firm fixed price contract has a period of performance from September 14, 2023 through October 5, 2023, with all work to be conducted by DMS Pharmaceutical at its facility located in Park Ridge, Illinois. No subcontractors or set aside designations were identified. The Defense...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,286.86 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562330077 VELCADE 3.5 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from September 15, 2023 through October 6, 2023. No subcontractors or set aside designations were identified. This delivery order was likely placed against DLA's Pharmaceutical Prime Vendor contract to...
The Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense, awarded a delivery order valued at approximately $2,287 to DMS Pharmaceutical Group Inc. for VELCADE 3.5 MG VIALS. The firm fixed price order is being carried out under an unspecified existing contract vehicle and calls for DMS Pharmaceutical to deliver the specified pharmaceutical product to a location in Park Ridge, Illinois. Performance is required between August 4 and August 25, 2023. As the DLA supports...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of a larger single-award indefinite delivery contract (IDC) with the DLA worth up to $499,999,999, which runs through December 31, 2025. The current delivery order is for $11,657.20 and is for the supply of 3.5 mg vials of the drug VELCADE. This order is placed under a firm fixed-price...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $23,314.40 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,566,129,177 vials of the prescription drug Velcade (bortezomib) for the treatment of multiple myeloma and mantle cell lymphoma. This delivery order was placed under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,465.50, is for the delivery of 3.5 milligram vials of the drug Velcade. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,744.20, is for the provision of Velcade 3.5 mg vials, with a period of performance ending on November 24, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...